Published in Angiogenesis on November 08, 2013
The Lymphatic System in Disease Processes and Cancer Progression. Annu Rev Biomed Eng (2016) 0.80
Impacts of Ionizing Radiation on the Different Compartments of the Tumor Microenvironment. Front Pharmacol (2016) 0.78
The non-canonical role of vascular endothelial growth factor-C axis in cancer progression. Exp Biol Med (Maywood) (2015) 0.77
Bridging the divide between pathogenesis and detection in lymphedema. Semin Cell Dev Biol (2014) 0.75
The Ki-67 protein: from the known and the unknown. J Cell Physiol (2000) 16.48
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol (2000) 13.46
Clonogenic assay of cells in vitro. Nat Protoc (2006) 11.85
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol (2003) 7.42
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res (1999) 4.17
Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J (2001) 3.88
VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development (1996) 2.82
Lymphedema: a comprehensive review. Ann Plast Surg (2007) 2.70
Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci U S A (2002) 2.30
Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med (2007) 2.29
ATM regulates target switching to escalating doses of radiation in the intestines. Nat Med (2005) 2.28
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J (1996) 1.95
SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro. Cancer Res (2003) 1.53
Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol (2004) 1.41
Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance. Cancer J (2002) 1.23
Breast radiotherapy and lymphedema. Cancer (1998) 1.16
VEGF-A induces angiogenesis, arteriogenesis, lymphangiogenesis, and vascular malformations. Cold Spring Harb Symp Quant Biol (2002) 1.15
Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. Am J Physiol Cell Physiol (2010) 1.09
Radiogenic lymphangiogenesis in the skin. Am J Pathol (2007) 0.95
Estrogen modulates paracellular permeability of human endothelial cells by eNOS- and iNOS-related mechanisms. Am J Physiol (1999) 0.94
Cancer. Targeting lymphatic metastasis. Science (2002) 0.90
Time-related changes in lymphatic clearance in pig skin after a single dose of 18 Gy of X rays. Br J Radiol (1991) 0.84
Intestinal and peri-tumoral lymphatic endothelial cells are resistant to radiation-induced apoptosis. Biochem Biophys Res Commun (2006) 0.84
The clonogenic response of bovine aortic endothelial cells in culture to radiation. Radiat Res (1986) 0.81
Negligible radiation protection of endothelial cells by vascular endothelial growth factor. Oncol Rep (2007) 0.79
The effects of radiation on the contractile activity of guinea pig mesenteric lymphatics. Lymphology (1994) 0.77
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell (2007) 12.52
Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nat Med (2009) 5.41
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. N Engl J Med (2009) 3.85
Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res (2006) 2.42
Impaired lymphatic contraction associated with immunosuppression. Proc Natl Acad Sci U S A (2011) 1.88
Characterization and comparison of the NR3A subunit of the NMDA receptor in recombinant systems and primary cortical neurons. J Neurophysiol (2002) 1.87
Differential response of primary tumor versus lymphatic metastasis to VEGFR-2 and VEGFR-3 kinase inhibitors cediranib and vandetanib. Mol Cancer Ther (2008) 1.83
Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function. Cancer Res (2004) 1.72
New insights on cell death from radiation exposure. Lancet Oncol (2005) 1.72
A novel mechanism of cyclooxygenase-2 inhibition involving interactions with Ser-530 and Tyr-385. J Biol Chem (2003) 1.69
Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression. J Natl Cancer Inst (2013) 1.69
Medium-mediated intercellular communication is involved in bystander responses of X-ray-irradiated normal human fibroblasts. Oncogene (2005) 1.60
Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res (2006) 1.60
In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts. Nat Methods (2009) 1.48
Primary cardiac sarcoma. Ann Thorac Surg (2010) 1.45
Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using error-suppressed multiplexed deep sequencing. Cancer Res (2012) 1.39
The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells. Proc Natl Acad Sci U S A (2004) 1.36
Stewart-Treves syndrome of the lower extremity. J Clin Oncol (2010) 1.32
Endothelial nitric oxide synthase regulates microlymphatic flow via collecting lymphatics. Circ Res (2004) 1.30
Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects. Int J Radiat Oncol Biol Phys (2011) 1.24
Platelet-derived growth factor receptor-beta in Gorham's disease. Nat Clin Pract Oncol (2006) 1.23
Lymphotoxin-alpha contributes to lymphangiogenesis. Blood (2010) 1.19
Characterization of Torin2, an ATP-competitive inhibitor of mTOR, ATM, and ATR. Cancer Res (2013) 1.16
Structural basis of enantioselective inhibition of cyclooxygenase-1 by S-alpha-substituted indomethacin ethanolamides. J Biol Chem (2007) 1.16
Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis. Cancer Res (2009) 1.13
Multiscale measurements distinguish cellular and interstitial hindrances to diffusion in vivo. Biophys J (2009) 1.12
Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2. Biochem Biophys Res Commun (2002) 1.12
Targeting unique metabolic properties of breast tumor initiating cells. Stem Cells (2014) 1.10
BACE1 modulates filopodia-like protrusions induced by sodium channel beta4 subunit. Biochem Biophys Res Commun (2007) 1.08
Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys (2006) 1.06
Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival. Clin Cancer Res (2012) 1.03
Molecular mechanisms of metastasis. Cancer Metastasis Rev (2006) 1.00
Antitumor activity of Triolimus: a novel multidrug-loaded micelle containing Paclitaxel, Rapamycin, and 17-AAG. Mol Cancer Ther (2012) 1.00
Combined vascular endothelial growth factor-targeted therapy and radiotherapy for rectal cancer: theory and clinical practice. Semin Oncol (2006) 0.98
Phototoxicity of Hoechst 33342 in time-lapse fluorescence microscopy. Photochem Photobiol Sci (2010) 0.98
Accelerated partial breast irradiation using proton beams: Initial dosimetric experience. Int J Radiat Oncol Biol Phys (2006) 0.98
AIDS-related Kaposi's sarcoma of the gastrointestinal tract. J Clin Oncol (2010) 0.97
Bystander effects induced by diffusing mediators after photodynamic stress. Radiat Res (2009) 0.96
The time dependence of bystander responses induced by iron-ion radiation in normal human skin fibroblasts. Radiat Res (2007) 0.96
Immunologically augmented cancer treatment using modern radiotherapy. Trends Mol Med (2013) 0.95
Deficiencies of double-strand break repair factors and effects on mutagenesis in directly gamma-irradiated and medium-mediated bystander human lymphoblastoid cells. Radiat Res (2008) 0.95
Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells. Neoplasia (2007) 0.94
Video-rate resonant scanning multiphoton microscopy: An emerging technique for intravital imaging of the tumor microenvironment. Intravital (2012) 0.93
Ionizing radiation-induced bystander mutagenesis and adaptation: quantitative and temporal aspects. Mutat Res (2009) 0.93
Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation. Cancer Res (2013) 0.92
Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer. Oncologist (2012) 0.92
Novel molecular pathways in Gorham disease: implications for treatment. Pediatr Blood Cancer (2013) 0.91
Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience. Am J Clin Oncol (2014) 0.90
Lymphatic function and immune regulation in health and disease. Lymphat Res Biol (2013) 0.89
Biomarkers and mechanisms of FANCD2 function. J Biomed Biotechnol (2008) 0.89
Molecular regulation of microlymphatic formation and function: role of nitric oxide. Trends Cardiovasc Med (2005) 0.89
Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(D, L-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin. J Control Release (2012) 0.89
Agreement among RTOG sarcoma radiation oncologists in contouring suspicious peritumoral edema for preoperative radiation therapy of soft tissue sarcoma of the extremity. Int J Radiat Oncol Biol Phys (2013) 0.89
Expression of a fibroblast growth factor-binding protein during the development of adenocarcinoma of the pancreas and colon. Cancer Res (2006) 0.89
Lymphatic vessels in health and disease. Wiley Interdiscip Rev Syst Biol Med (2012) 0.88
Estrogen enhanced cell-cell signalling in breast cancer cells exposed to targeted irradiation. BMC Cancer (2008) 0.87
Efficacy of Tie2 receptor antagonism in angiosarcoma. Neoplasia (2012) 0.86
N-methyl-D-aspartate receptor subunit NR3A in the retina: developmental expression, cellular localization, and functional aspects. Invest Ophthalmol Vis Sci (2003) 0.86
Expression of angiopoietin-TIE system components in angiosarcoma. Mod Pathol (2013) 0.84
Real-time imaging of novel spatial and temporal responses to photodynamic stress. Free Radic Biol Med (2009) 0.84
FANCD2-deficient human fibroblasts are hypersensitive to ionising radiation at oxygen concentrations of 0% and 3% but not under normoxic conditions. Int J Radiat Biol (2009) 0.84
Correspondence re: S. Maula et al., intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinoma of the head and neck. Cancer Res., 63: 1920-1926, 2003. Cancer Res (2003) 0.83
Introduction to clinical radiation biology. Hematol Oncol Clin North Am (2006) 0.83
Development. Lymphatics make the break. Science (2003) 0.82
Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy. Gastrointest Cancer Res (2011) 0.82
Prevention and treatment of lymphatic metastasis by antilymphangiogenic therapy. J Natl Cancer Inst (2002) 0.82
Targeted and non-targeted effects from combinations of low doses of energetic protons and iron ions in human fibroblasts. Int J Radiat Biol (2010) 0.82
Computational modelling of anti-angiogenic therapies based on multiparametric molecular imaging data. Phys Med Biol (2012) 0.81
External beam radiotherapy for colon cancer: patterns of care. Int J Radiat Oncol Biol Phys (2009) 0.81
cPLA2-interacting protein, PLIP, causes apoptosis and decreases G1 phase in mesangial cells. Am J Physiol Renal Physiol (2005) 0.81
Stage-specific survival differences associated with postoperative radiotherapy for gastrointestinal cancers. J Gastrointest Cancer (2009) 0.81
Do the dietary supplements epigallocatechin gallate or vitamin e cause a radiomodifying response on tumors in vivo? A pilot study with murine breast carcinoma. J Soc Integr Oncol (2007) 0.80
Relative biological effectiveness (RBE) and out-of-field cell survival responses to passive scattering and pencil beam scanning proton beam deliveries. Phys Med Biol (2012) 0.80
Refusal of radiation therapy and its associated impact on survival. Am J Clin Oncol (2010) 0.80
Differential bystander signaling between radioresistant chondrosarcoma cells and fibroblasts after x-ray, proton, iron ion and carbon ion exposures. Int J Radiat Oncol Biol Phys (2012) 0.80
American Society for Radiation Oncology (ASTRO) survey of radiation biology educators in U.S. and Canadian radiation oncology residency programs. Int J Radiat Oncol Biol Phys (2009) 0.80
Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice. J Cell Physiol (2009) 0.80
Acute hematologic and mucosal toxicities in head and neck cancer patients undergoing chemoradiotherapy: a comparison of 3D-CRT, IMRT, and helical tomotherapy. Technol Cancer Res Treat (2013) 0.80
Notch leads lymphatics and links them to blood vessels. Arterioscler Thromb Vasc Biol (2010) 0.79
The role of radiation in retroperitoneal sarcomas. Curr Treat Options Oncol (2013) 0.79
Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors. Clin Cancer Res (2010) 0.79
Adjuvant radiotherapy for pancreatic cancer is associated with a survival benefit primarily in stage IIB patients. J Gastroenterol (2009) 0.79
Studies on the metabolism of the novel, selective cyclooxygenase-2 inhibitor indomethacin phenethylamide in rat, mouse, and human liver microsomes: identification of active metabolites. Drug Metab Dispos (2004) 0.78
A one, two punch for liver cancer: anti-angiogenesis with a death receptor agonist. Cancer Biol Ther (2009) 0.77
Low rates of heterotopic ossification after resurfacing hip arthroplasty with use of prophylactic radiotherapy in select patients. J Arthroplasty (2012) 0.77
Statin use in cancer patients with brain metastases: a missed communication opportunity at the end of life. Support Care Cancer (2015) 0.77
Anti-VEGFR-3 therapy and lymph node metastasis [corrected]. Cancer Res (2007) 0.75
Impact of a Contralateral Tumor Nodule on Survival in Non-Small-Cell Lung Cancer. J Thorac Oncol (2015) 0.75
Optimizing outcomes of chemoradiation in the management of squamous cell carcinoma of the anal canal. Oncology (Williston Park) (2010) 0.75
Choroid plexus tumor epidemiology and outcomes: implications for surgical and radiotherapeutic management. J Neurooncol (2014) 0.75